-
Universal CAR-NK for relapsed/refractory acute myeloid leukemia (AML), 3/5 cases achieved CR
Time of Update: 2022-05-25
The most intriguing clinical data is that high-dose ( 10x108 or 15x108 CAR -NK cells, 3 infusions) showed a good response in AML, with 3 CRs in 5 subjects, of which 2 had minimal MRD.
-
National Medical Insurance Administration: China has vaccinated 3.2 billion doses of vaccines, costing more than 120 billion yuan
Time of Update: 2022-05-25
negotiated with the company many times, and pushed the company to continuously reduce the price, which has been reduced to about 40 yuan/dose and 20 yuan/dose . At the same time, cooperate
-
NEJM: How effective was the fourth dose of the Covid-19 mRNA vaccine BNT162b2?
Time of Update: 2022-05-25
A fourth dose of the BNT162b2 vaccine was effective in reducing the short-term risk of Covid-19-related outcomes in individuals who had received a third dose of the vaccine at least 4 months earlier .
-
Why World Immunization Week Vaccinations Are Beneficial
Time of Update: 2022-05-25
Vaccination is a simple, safe and effective way to protect people from harmful diseases before they are exposed to them, by training a person's immune system to produce antibodies, the WHO said .
-
Brain: Glial fibrillary acidic protein and neurofilament light chain levels 8 months after brain trauma predict brain structural changes 5 years later
Time of Update: 2022-05-24
and whole brain white matter in subgroups of patients who showed improvement (1 point increase in GOSE), stable (no change in GOSE), or worsening (1 point decrease in GOSE) between 8 months and 5 years after injury (Fig. A and B) and predicted
-
JNNP: Parsonian-Turner syndrome after CVID-19 vaccination
Time of Update: 2022-05-24
Confirming findings from previous case reports, our observations suggest that the COVID-19 vaccine may be associated with ipsilaterally occurring PTS, possibly with reactive lymphadenopathy .
-
Lihe Technology will invest 130 million yuan to obtain a 5% stake in Shanghai Survey and Design Research Institute
Time of Update: 2022-05-24
of the first (38 nationwide) national engineering research centers to be included in the new sequence management. It is a co-construction unit of the National Engineering Research Center for Greenhouse Gas Monitoring Technology and Equipment
-
Fotivda milestone 5-year follow-up data: efficacy beats Nexavar!
Time of Update: 2022-05-23
Milestone 5-year follow-up data show patients treated with Fotivda achieved long-term disease compared with Bayer's targeted cancer drug Nexavar (Nexavar, generic name: sorafenib) in 3- and 4-line RCC patients Progression-free survival (PFS) was 5 times more likely .
-
Pfizer's new crown vaccine Comirnaty and oral drug Paxlovid miss first-quarter sales
Time of Update: 2022-05-23
The reason for the downgrade is that the team's latest forecast believes that the sales revenue of Pfizer's new crown oral drug Paxlovid and new crown vaccine Comirnaty will be lower than expected in Q1 this year .
-
Announcement of Henan Provincial Market Supervision and Administration Bureau on 36 batches of unqualified food (No. 5, 2022)
Time of Update: 2022-05-23
> 5. 1 batch of round pots and 1 batch of bowls used by Laike Dapanji Xingyun Road Store in the west of Erqi District, Zhengzhou City, the detection values of coliform bacteria were all detected, and the standard stipulated
-
Sri Lanka Microorganism Announces Collaboration with Baidu Research Institute to Accelerate mRNA Vaccine and Drug Development with AI Empowerment
Time of Update: 2022-05-22
In addition to expanding the optimization of linear mRNA algorithm research, the two parties will try to develop circular RNA and other sequence design iteration technologies.
-
Pfizer's 20-valent pneumococcal polysaccharide conjugate vaccine declares for clinical application in China
Time of Update: 2022-05-22
Article source: Medical Cube InfoAuthor: infoOn April 1, the CDE official website showed that Pfizer's 20-valent pneumococcal polysaccharide conjugate vaccine (PREVNAR 20, PCV20) has been accepted by the State Food and Drug Administration for clinical applications in China .
-
The two departments set a goal: in the next 5 years, the output of degradable fiber will increase by an average of 20%+!
Time of Update: 2022-05-22
above designated size has an average annual growth rate of 5%, and the proportion of chemical fiber output in the world is basically stable . >The innovation capability has been
-
Developing Oral mRNA Vaccines!
Time of Update: 2022-05-22
on a licensing agreement for Matinas' LNC delivery platform technology . >Headquartered in New Jersey, USA, Matinas has been operating since 2013 and is focused on redefining
-
WHO's latest recommendation: HPV vaccine is effective with only one shot, and this evidence is very important!
Time of Update: 2022-05-22
The SAGE review concluded that the single-dose human papillomavirus (HPV) vaccine provided solid protection against HPV, the virus that causes cervical cancer, comparable to the two-dose regimen .
-
Jining Municipal Market Supervision and Administration Bureau Food Safety Supervision and Sampling Information Notice (2022 No. 5)
Time of Update: 2022-05-21
The self-sterilizing plate used by the Weilong Food and Beverage Department in Zoucheng City, the coliform group project does not meet the national food safety standards, and the inspection agency is Zhongpan Anxin (Qingdao) Testing Technology Co.
-
mRNA vaccine helps CAR-T therapy in solid tumors with an overall response rate of 43%
Time of Update: 2022-05-21
At the ongoing AACR annual meeting, BioNTech announced the results of the first human clinical trial of BNT211, a next-generation CAR-T therapy targeting solid tumors
-
$5 billion large variety was looted Chia Tai Tianqing entered the game
Time of Update: 2022-05-21
Figure 1: The latest products declared by Chia Tai Tianqing Pharmaceutical Group Source: CDE official website It is reported that palbociclib was first developed by Pfizer and is the first CDK4/6 inhibitor to be marketed in the world.
-
A new form of vaccine - spherical nucleic acid vaccine, the first application of the new crown, the effect is amazing, has been used for cancer treatment
Time of Update: 2022-05-20
The research team developed an experimental spherical nucleic acid (SNA) drug, which was demonstrated in a clinical trial against lethal glioblastoma to penetrate the blood-brain barrier, suppress oncogene expression levels, and trigger tumor cell death .
-
Guangzhou Market Supervision and Administration Bureau 2022 Issue 5 Food Safety Supervision and Sampling Information
Time of Update: 2022-05-20
/> 4. There were 40 batches of alcohol, and no unqualified samples were detected . 5.
